Grund Nicholas
Insider CIK 1661887 · AKBA Chief Commercial Officer · AMAG Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKBA Akebia Therapeutics, Inc. | S Sale | 2026-02-02 | 2026-02-04 | 31,244 | $1.39 | $43.4K | 561,750 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2026-02-02 | 2026-02-04 | 53,585 | $1.39 | $74.5K | 592,994 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2026-01-30 | 2026-02-03 | 320,000 | — | $0 | 320,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2026-01-30 | 2026-02-03 | 204,000 | — | $0 | 646,579 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-04 | 55,621 | $2.10 | $116.8K | 442,579 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 292,300 | — | $0 | 292,300 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2025-01-31 | 2025-02-04 | 194,900 | — | $0 | 498,200 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 454,950 | — | $0 | 454,950 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2024-01-31 | 2024-02-02 | 303,300 | — | $0 | 303,300 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | F Tax w/h | 2019-03-02 | 2019-03-05 | 982 | $14.76 | $14.5K | 84,805 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2019-02-25 | 2019-02-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2019-02-25 | 2019-02-27 | 12,000 | — | $0 | 85,787 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2019-02-25 | 2019-02-27 | 12,000 | — | $0 | 73,787 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | F Tax w/h | 2019-02-23 | 2019-02-26 | 982 | $15.51 | $15.2K | 61,787 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | F Tax w/h | 2019-01-04 | 2019-01-08 | 3,555 | $16.19 | $57.6K | 62,769 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2018-03-02 | 2018-03-06 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2018-03-02 | 2018-03-06 | 12,000 | — | $0 | 70,517 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | F Tax w/h | 2018-03-02 | 2018-03-06 | 4,193 | $21.00 | $88.1K | 66,324 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2018-03-02 | 2018-03-06 | 10,000 | — | $0 | 58,517 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | F Tax w/h | 2017-05-08 | 2017-05-10 | 3,483 | $18.55 | $64.6K | 48,517 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2017-02-23 | 2017-02-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2017-02-23 | 2017-02-27 | 10,000 | — | $0 | 52,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2017-02-23 | 2017-02-27 | 10,000 | — | $0 | 42,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award deriv | 2016-01-04 | 2016-01-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS INC. | A Award | 2016-01-04 | 2016-01-05 | 32,000 | — | $0 | 32,000 | SEC↗ |